CRISPR uni­corn Mam­moth backs off di­ag­nos­tics re­search, lay­ing off 35 on test­ing team to fo­cus on ther­a­peu­tics

Mam­moth Bio­sciences is tak­ing a big step away from its orig­i­nal am­bi­tion of up­end­ing the di­ag­nos­tics busi­ness with CRISPR, and has laid off the bulk of its em­ploy­ees work­ing on test­ing.

The Bris­bane, CA-based start­up laid off 35 peo­ple, or less than 20% of its work­force, in March, Mam­moth CEO Trevor Mar­tin con­firmed to End­points News. The cuts have not been pre­vi­ous­ly re­port­ed, and pri­mar­i­ly af­fect­ed peo­ple work­ing on the di­ag­nos­tics team.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER